Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil, +213

The Lancet

Neoadjuvant TherapyChemotherapy Versus CetuximabMedicinePathologyHead And Neck Cancer +5

Diagnosing lung cancer in exhaled breath using gold nanoparticles

Gang Peng, Ulrike Tisch, Orna Adams, +7

Nature Nanotechnology

NanoparticlesNanomedicineEngineeringMetal NanoparticlesNanotechnology +2

Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors

Gang Peng, Marwan Hakim, Yoav Y. Broza, +5

British Journal of Cancer

Diagnosis of head-and-neck cancer from exhaled breath

Marwan Hakim, Salem Billan, Ulrike Tisch, +6

British Journal of Cancer

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial

Brett Hughes, Eva Muñoz‐Couselo, Laurent Mortier, +14

Annals of Oncology

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra, +185

The Lancet Oncology

Concurrent ChemoradiotherapyNeoadjuvant TherapySquamous Cell CarcinomaMedicineHead And Neck Cancer +4

Classification of breast cancer precursors through exhaled breath

Gregory Shuster, Zahava Gallimidi, Asnat Heyman Reiss, +8

Breast Cancer Research and Treatment

Breast OncologyCancer DetectionMedicinePathologyBreast Imaging +2

Improving the rate of negative margins after surgery for oral cavity squamous cell carcinoma: A prospective randomized controlled study

Moran Amit, Shorook Na’ara, Leonor Leider–Trejo, +4

Head & Neck

An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck

Vassiliki Saloura, Ezra E.W. Cohen, Lisa Licitra, +4

Cancer Chemotherapy and Pharmacology

Phase Ii TrialMalignant DiseaseOpen-label Single-armMedicinePathology +7

Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot study

Amichay Meirovitz, Michal Kuten, Salem Billan, +6

Radiation Oncology